Indirect-acting dopaminergic drugs, such as monoamine oxidase inhibitors (MAOIs), enzymes' main purpose is the breakdown of __________.

Prepare for the EDAPT Intracranial Regulation Test with interactive flashcards and multiple choice questions. Each question is accompanied by helpful hints and explanations to boost your readiness. Get started today and ensure your success!

Multiple Choice

Indirect-acting dopaminergic drugs, such as monoamine oxidase inhibitors (MAOIs), enzymes' main purpose is the breakdown of __________.

Explanation:
MAO enzymes regulate neurotransmitter signaling by breaking down monoamines in the brain. Among the substrates, the catecholamines—dopamine and norepinephrine (and to some extent epinephrine)—are major targets. Indirect-acting dopaminergic drugs like MAO inhibitors work by blocking this breakdown, raising synaptic levels of these neurotransmitters. Dopamine or norepinephrine alone don’t capture the full range of MAO’s primary substrates, since serotonin is also affected but is not a catecholamine. Thus, the best fit is catecholamines.

MAO enzymes regulate neurotransmitter signaling by breaking down monoamines in the brain. Among the substrates, the catecholamines—dopamine and norepinephrine (and to some extent epinephrine)—are major targets. Indirect-acting dopaminergic drugs like MAO inhibitors work by blocking this breakdown, raising synaptic levels of these neurotransmitters. Dopamine or norepinephrine alone don’t capture the full range of MAO’s primary substrates, since serotonin is also affected but is not a catecholamine. Thus, the best fit is catecholamines.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy